Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / novo nordisk weight loss drug patent battle against mwn benzinga

VTRS - Novo Nordisk Weight Loss Drug Patent Battle Against Viatris - Emerges As Winner | Benzinga

Viatris Inc.

Novo Nordisk A/S (NYSE: NVO) successfully defended two pivotal patent claims linked to the main ingredient in its popular weight-loss and diabetes drugs, Wegovy and Ozempic. 

Viatris Inc (NASDAQ: VTRS), via its subsidiary Mylan Pharmaceuticals, had instigated challenges aiming to pave the way for generic versions of these drugs but was thwarted by a ...

Full story available on Benzinga.com
Stock Information
Company Name: Viatris Inc.
Stock Symbol: VTRS
Market: NASDAQ
Menu
VTRS VTRS Quote VTRS Short VTRS News VTRS Articles VTRS Message Board
Get VTRS Alerts

News, Short Squeeze, Breakout and More Instantly...